Cargando…
Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study
The prevalence of hyperuricemia and chronic kidney disease (CKD) has been steadily increasing. The role of hyperuricemia and efficacy of uric acid-lowering agents against CKD progression remain controversial. This study aimed to evaluate the effect of hyperuricemia and uric acid-lowering agents on t...
Autores principales: | Oh, Tae Ryom, Choi, Hong Sang, Kim, Chang Seong, Bae, Eun Hui, Ma, Seong Kwon, Sung, Su-Ah, Kim, Yong-Soo, Oh, Kook Hwan, Ahn, Curie, Kim, Soo Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491556/ https://www.ncbi.nlm.nih.gov/pubmed/31040373 http://dx.doi.org/10.1038/s41598-019-43241-3 |
Ejemplares similares
-
High serum adiponectin as a biomarker of renal dysfunction: Results from the KNOW-CKD study
por: Song, Su Hyun, et al.
Publicado: (2020) -
Association between vitamin D deficiency and health-related quality of life in patients with chronic kidney disease from the KNOW-CKD study
por: Oh, Tae Ryom, et al.
Publicado: (2017) -
Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
por: Suh, Sang Heon, et al.
Publicado: (2022) -
Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study
por: Kim, Chang Seong, et al.
Publicado: (2016) -
Abdominal Aortic Calcification and Cardiovascular Outcomes in Chronic Kidney Disease: Findings from KNOW-CKD Study
por: Suh, Sang Heon, et al.
Publicado: (2022)